FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle

Journal of Dermatological Science

Volumn 12, Issue 3, 1996, Pages 246-254

  Karashima, Tadashi ^a   Hachisuka, Hiroshi ^a   Sasai, Yoichiro ^a  

^a KURUME UNIVERSITY   (Japan)

Author keywords

Cell culture; Cell cycle; Cyclosporin A; FK506; Human keratinocytes

Indexed keywords

CYCLOSPORIN A; EPIDERMAL GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; TACROLIMUS; TRANSFORMING GROWTH FACTOR;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS;

EID: 0030246916     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-1811(95)00480-7     Document Type: Article

References (37)

1. [1] Gottlieb AB, Lifshitz B, SM Fu, Staiano-Coico L, Wang CY, Carter DM: Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 164: 1013-1028, 1986.
2. [2] Terui T, Aiba S, Kato T, Tanaka T, Tagami H: HLA-DR antigen expression on keratinocyte in highly inflamed parts of psoriatic lesions. Br J Dermatol 116: 87-93, 1987.
3. [3] Griffiths CEM, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20: 617-629, 1989.
4. [4] Singer K, Tuck DT, Sampson HA, Hall RP: Epidermal keratinocytes express the adhesion molecule intercellular adhesion molecule-1 in inflammatory dermatoses. J Invest Dermatol 92: 746-750, 1989.
5. [5] Elder JT, Fisher GJ, Lindquist PB, Bennet GL, Pittelkow MR, Coffey RJ, Ellingsworth L, Derynck R, Voorhees JJ: Overexpression of transforming growth factor α in psoriatic epidermis. Science 243: 811-814, 1989.
6. [6] Gearing AJH, Fincham NJ, Bird CR, Wadhwa M, Cartwright AJE, Camp RDR: Cytokines in skin lesions of psoriasis. Cytokine 2: 68-75, 1990.
7. [7] Yoshizaki K, Nishimoto N, Matsumoto K, Tagoh H, Taga T, Deguchi Y, Kuritani T, Hirano T, Hashimoto K, Okada N, Kishimoto T: Interleukin 6 and expression of its receptor on epidermal keratinocytes. Cytokine 2: 381-387, 1990.
8. [8] Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367-6371, 1989.
9. [9] Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1 IL-S mRNA in situ. J Invest Dermatol 97: 73-79, 1991.
10. [10] Shipley GD, Childs CB, Volkenant ML, Moses HL: Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells. Cancer Res 44: 710-716, 1984.
11. [11] Barrandon Y, Green H: Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor α and epidermal growth factor. Cell 50: 1131-1137, 1987.
12. [12] Shipley, GD, Pittelkow MR: Control of growth and differentiation in vitro of human keratinocytes cultured in serum-free medium. Arch Dermatol 123: 1541a-1544a, 1987.
13. [13] Vassar R, Fuchs E: Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev 5: 714-727, 1991.
14. 125I] epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol 86: 260-265, 1986.
15. [15] Gottlieb AB, Chang CK, Posnett DN, Fanelli B, Tam JP: Detection of transforming growth factor α in normal, malignant, and hyperproliferative human keratinocytes. J Exp Med 167: 670-675, 1988.
16. [16] Marks J: Psoriasis. Br Med J 293: 509, 1986.
17. [17] Griffiths CEM, Powles AV, Leonard JN, Fry L, Baker BS, Valdimarsson H: Clearance of psoriasis with low dose cyclosporin. Br Med J 293: 731-732, 1986.
18. [18] Ellis CN, Gorsulowski DC, Hamilton TA, Nillings JK, Brown MD, Headington JT, Cooper KD, Baadsgaard O, Duell EA, Annesley TM, Turcotte JG, Voorhees JJ: Cyclosporine improves psoriasis in a double-blind study. J Am Med Assoc 256: 3110-3116, 1986.
19. [19] Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Abu-Elmagd K, Starzl TE: Tacrolimus (FK 506) a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 128: 781-785, 1992.
20. [20] Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Gotto T, Okuhara M, Aoki H, Ochiai T: FK506, a novel immunosuppressant isolated from a streptomycetes. II. Immunosuppressive effect of FK 506 in vitro. J Antibiot 40: 1256-1265, 1987.
21. [21] Fisher GJ, Duel EA, Nickoloff BJ, Annesley TM, Kowalke JK, Ellis CN, Voorhees JJ: Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media. J Invest Dermatol 91: 142-146, 1988.
22. [22] Duncan JI: Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK 506, and repamycin. J Invest Dermatol 102: 84-88, 1994.
23. [23] Khandke L, Krane JF, Ashinoff R, Staiano-Coico L, Granelli-Piperno A, Luster AD, Carter M, Krueger JG, Gottlieb AB: Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor α epidermal growth factor receptor pathways. Arch Dermatol 127: 1172-1179, 1991.
24. [24] Ristow HJ: Interleukin-1 does not stimulate DNA synthesis of cultured human keratinocytes growth-arrested in growth-factor-depleted medium. J Invest Dermatol 95: 688-692, 1990.
25. [25] Shipley G, Pittelkow, Wille JJ Jr. Scott RE, Moses HL: Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 46: 2068-2071, 1986.
26. [26] Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM, Moses HL: TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777-785, 1990.
27. [27] Waseem NH, Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conversation and the detection of a nuclear form. J Cell Sci 96: 121-129, 1990.
28. [28] Urabe A, Kanitakis J, Viae J, Yhivolet J: Cyclosporin A inhibits directly in vivo keratinocyte proliferation of living human skin. J Invest Dermatol 92: 755-757, 1989.
29. [29] Schulz BS, Michel G, Wagner S, Suss R, Beetz A, Peter RU, Kemeny L, Ruzicka T: Increased expression of epidermal IL-8 receptor in psoriasis. J Immunol 151: 4399-4406, 1993.
30. [30] Won YH, Sauder DN, McKenzie RC: Cyclosporin A inhibits keratinocyte cytokine gene expression. Br J Dermatol 130: 312-319, 1994.
31. [31] Urabe A, Nakayama J, Terao H, Hori Y: Increased binding sites of dansylated cyclosporin A in psoriatic epidermis grafted onto nude mice during cyclosporin A treatment. Eur J Dermatol 1: 61-64, 1991.
32. [32] Nickoloff BJ, Fisher GJ, Nitra RJ, Voorhees JJ: Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes. Am J Pathol 131: 12-18, 1988.
33. [33] Furue M, Gaspari AA, Katz SI: The effect of cyclosporin A on epidermal cells. II. Cyclosporin A inhibits proliferation of normal and transformed keratinocytes. J Invest Dermatol 90: 796-800, 1988.
34. [34] Takahashi H, Iizuka H: Neither cyclosporin A nor FK506 affects adenylate cyclase responses of fetal rat keratinizing epidermal cells (FRSK cells) at concentrations that inhibit thymidine incorporation. J Dermatol Sci 6: 235-239, 1993.
35. [35] Frentz G, Moller U, Christensen I: DNA flow cytometry on human epidermis: I. Methodological studies on normal skin. J. Invest Dermatol 74: 119-121, 1980.
36. [36] Staiano-Coico L, Higgins PJ, Darzynkiewicz Z, Kimmel M, Gottlieb AB, Pagan-Charry I, Madden MR, Finkelstein JL, Hefton JM: Human keratinocyte culture identification and staging of epidermal cell subpopulations. J Clin Invest 77: 396-404, 1986.
37. [37] Mansbridge JN, Knapp AM: Changes in keratinocyte maturation during wound healing. J Invest Dermatol 89: 253-263, 1987.